Citations (8)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kamal S Saini, Kevin Punie, Chris Twelves, Stefanella Bortini, Evandro de Azambuja, Steven Anderson, Carmen Criscitiello, Ahmad Awada & Sherene Loi. (2021) Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics. Expert Opinion on Biological Therapy 21:7, pages 945-962.
Read now
Read now
Articles from other publishers (7)
Matthew Roberts, Julia Ogden, AS Mukarram Hossain, Anshuman Chaturvedi, Alastair RW Kerr, Caroline Dive, Jennifer Ellen Beane & Carlos Lopez-Garcia. (2023) Interrogating the precancerous evolution of pathway dysfunction in lung squamous cell carcinoma using XTABLE. eLife 12.
Crossref
Crossref
Shivani Mathur, Laura Prince, Oliver Bucher, Lin Xue, Shantanu Banerji & David E. Dawe. (2022) The impact of the modified frailty index on clinical outcomes for patients with stage IV non-small cell lung cancer receiving chemotherapy. Journal of Geriatric Oncology 13:5, pages 654-661.
Crossref
Crossref
Triana Rivera-Megias, Nhut M. Le & Alonso Heredia. 2022. HIV Reservoirs. HIV Reservoirs
229
251
.
Ilenia Chatziandreou, Adriana Psaraki, Konstantinos Paschidis, Andreas C. Lazaris & Angelica A. Saetta. (2021) Evidence for frequent concurrent DCUN1D1, FGFR1, BCL9 gene copy number amplification in squamous cell lung cancer. Pathology - Research and Practice 221, pages 153412.
Crossref
Crossref
Eleni Skavatsou, Maria Semitekolou, Ioannis Morianos, Theodoros Karampelas, Nikolaos Lougiakis, Georgina Xanthou & Constantin Tamvakopoulos. (2021) Immunotherapy Combined with Metronomic Dosing: An Effective Approach for the Treatment of NSCLC. Cancers 13:8, pages 1901.
Crossref
Crossref
John Thomas Palathingal, Basil Sunny & Vismaya Vijayan. (2021) Combining Chemotherapy with Immunotherapy in Colorectal Cancer: A Review. Clinical Cancer Drugs 8:1, pages 10-17.
Crossref
Crossref
Muhammad Khan, Zhihong Zhao, Sumbal Arooj, Yuxiang Fu & Guixiang Liao. (2020) Soluble PD-1: Predictive, Prognostic, and Therapeutic Value for Cancer Immunotherapy. Frontiers in Immunology 11.
Crossref
Crossref